“a slight trend”

There was no difference between ischemic retinae and those treated with the VEGF inhibitors (beva: p = 0.75; rani: p = 0.27), although a slight trend to fewer Bax + cells was observed in the ranibizumab-treated group in relation to the ischemic group ( p = 0.27).

In contrast, cortical arterioles in infant mice showed only a slight trend toward dilation (113.0 ± 1.6%, P = 0.27, at 15 min), which did not reach statistical significance compared to awake conditions.

In the multivariable model, neither age, BMI, good response to injection, nor follow-up duration were found to be significant predictors of ASES scores. The bone resection group demonstrated a slight trend towards increased patient satisfaction with the surgery (75.9% versus 57.1% (P = 0.274)) Conclusions: This study demonstrates that both soft-tissue-only debridement and bony resection of the superior medial angle of the scapula achieve similar functional and pain outcomes in patients with scapulothoracic bursitis.

Systemic exposure to obinutuzumab after the Cycle 8 dose ( AUC 21d value) was not dependent on body weight for any of the three lymphoma types (Figure 3 ), although a slight trend for decreased AUC with increased body weight was seen for FL patients ( P = 0.286; P = 0.876 for DLBCL; P = 0.897 for CLL).

Although it appeared that there was a slight trend toward higher titers in the rat IgG–treated control group, there was no statistical difference (P = 0.29).

5 B, unpaired t -test, P = 0.0396) and a slight trend of lower αSMA expression ( Fig. 5 C, paired t -test, P = 0.298).

A slight trend towards decreased number of infiltrating cells was found in RSV mice ( S6A Fig , P = 0.30, 20 heart sections analyzed from each of 10–13 mice per group).

We did not find an association when investigating all menopausal women, but could see a slight trend of earlier menopause being more frequent in women who smoke (65% vs. 57%, p = 0.3), when excluding the women of black ethnicity (who have an earlier menopause, but smoke less).

Although there was a slight trend toward improved survival in patients with triple positive cells, this difference was not statistically significant (p=0.308).

We noted a slight trend for GRIA1 to decrease in A-T patient-derived iPSCs ( GSE35347 : log2 fold-change of −0.024 ± 0.018, P = 0.311; one-way ANOVA followed by post hoc Bonferroni test; and GSE45030 : log2 fold-change of −0.022 ± 0.1440, P = 0.91; unpaired Student’s t -test) 62 , 63 , A-T patient-derived fibroblast ( GSE

While there was a slight trend favoring nurse-led care at 12 weeks post-discharge, the effect was not statistically significant (SMD = 0.23; 95%CI:−0.23,0.70; p = 0.33).

bevacizumab group, pemetrexed did not exhibit an obvious change in PFS (HR = 0.96, p = 0.752; I 2 = 35.8%, p = 0.212) or OS (HR = 0.98, p = 0.744, I 2 = 0.0%) but exhibited a slight trend to reduce grade 3–4 AEs (HR = 0.79, p = 0.343, I 2 = 65.7, p = 0.088).

No significant differences could be observed in terms of ciliation, although a slight trend towards increased ciliation could be seen in mutant cultures ( p = 0.35).

(2024) ( 25 ), the occurrence of irAEs was found to be associated with a slight trend of better outcome with a mOS not reached versus 12 months (95% CI, 9.3-14.7; p=0.35) and mPFS of 11 months (95% CI, 3.4-18.5) versus 8 months (95% CI, 7.1-8.9; p=0.401).

Minimal regulation of pleiotropic immunomodulatory cytokines Regarding the pleiotropic cytokines, a slight trend towards an IL-13 (control: 3.12±0.19 pg/ml, DR: 2.85±0.14 pg/ml; p = 0.36; Fig 2C ) down-regulation was observed in DR samples.

Furthermore, there was a slight trend toward reporting of blunting of feelings ( P = 0.362), delusion ( P = 0.323), and obfuscation ( P = 0.577) in antibody-positive patients.

Although this estimate suggested a slight trend toward inferior DFS in mutated cases, the difference was not statistically significant (Z = 0.90, p = 0.37).

However, it was found in the current study that the comparison of the antegrade versus retrograde group shows a slight trend of a higher primary patency rate in the early postoperative time frame (89.5% vs. 75.0%, p = 0.379).

When looking at the linear frequency domain, for LF/HF, only a slight trend with small effect size towards a decreasing ratio value after yoga intervention could be identified (p = 0.383, g* = -0.263).

Regarding OS data after 2L line, we saw only a slight trend in favour of the Neo-RAS wt patients treated with anti-EGFR (33.6 mo vs 32.4 mo, P = 0.385), statistically limited due to sample size.

Although high t(11;14) patients demonstrated a slight trend toward superior EFS (Fig. 3 b), neither log-rank test for overall survival curve differences ( p = 0.39) nor Cox proportional hazards model (HR = 2.05, 95% CI: 0.37–11.2, p = 0.41) were statistically significant.

A slight trend of correlation was noted for ALT (R 2 = 0.3641, p = 0.3966), but this did not reach statistical significance ( Figure 4A ).

A study showed that the individuals with a cysteine substitution had worse renal survival, however, it was a slight trend without significance (p = 0.41) 15 .

By contrast, the low dose of CRF (250 ng) failed to significantly enhance active lever pressing over vehicle despite the possibility of a slight trend (Bonferroni, p = 0.42, n.s), and by itself the 30-sec CS+ elicited merely a modest rise of only 50% over pre-cue baseline in lever pressing after vehicle microinjections, which was less than half the maximum drug-enhanced levels.

Additionally, although not significant, there was a slight trend for improved OS and PFS among patients with neutrophil‐to‐lymphocyte ratios greater than five (OS p = 0.42, PFS p = 0.25) and above‐median neutrophil counts (OS p = 0.24, PFS p = 0.18).